Inventor
TAKASE SHIGEHIRO
JP32 patents
⚠️ This page may combine multiple inventors who share the name “TAKASE SHIGEHIRO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FUJISAWA PHARMACEUTICAL CO
27 patentsUS6656905B1Dec 2, 2003
Cyclic tetrapeptide compound and use thereof
FUJISAWA PHARMACEUTICAL CO36 citations92
US5187195AFeb 16, 1993
Anthraquinone derivatives and preparation thereof
FUJISAWA PHARMACEUTICAL CO45 citations90
US6110933AAug 29, 2000
Amino acid derivatives and their use as phospholipase A2 inhibitor
FUJISAWA PHARMACEUTICAL CO9 citations73
US5447854ASep 5, 1995
Production of cyclosporin A and/or C with a strain of NECTRIA
FUJISAWA PHARMACEUTICAL CO7 citations73
US4863926ASep 5, 1989
Nitro aliphatic compounds, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO5 citations73
US4767768AAug 30, 1988
Nitro aliphatic compounds, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO10 citations73
US5545542AAug 13, 1996
WB2663 substances and method for their production
FUJISAWA PHARMACEUTICAL CO13 citations71
US5279826AJan 18, 1994
Prophylactic/therapeutic composition for disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis
FUJISAWA PHARMACEUTICAL CO6 citations69
US5409701AApr 25, 1995
FR901451 substance, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO5 citations63
US6331521B1Dec 18, 2001
Echinocandine derivatives with antimicrobial activity
FUJISAWA PHARMACEUTICAL CO4 citations62
US5547934AAug 20, 1996
WF11243 substance
FUJISAWA PHARMACEUTICAL CO3 citations62
US5446022AAug 29, 1995
WF11243 substance
FUJISAWA PHARMACEUTICAL CO2 citations62
US5364624ANov 15, 1994
WS7622A mono- or di-sulfate, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations62
US5292510AMar 8, 1994
WS7622A mono- or di- sulfate, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations62
US5167958ADec 1, 1992
WS7622A, B, C and D substances, derivatives thereof, processes for preparation thereof and use for treatment of pulmonary emphysema and adult respiratory distress syndrome
FUJISAWA PHARMACEUTICAL CO3 citations62
US5021240AJun 4, 1991
WS7622A, B, C and D substances, derivatives thereof, processes for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO5 citations62
US4782088ANov 1, 1988
Nitro aliphatic compounds and use thereof
FUJISAWA PHARMACEUTICAL CO1 citations62
US4778804AOct 18, 1988
Nitro aliphatic compounds, process for preparation thereof and use thereof
FUJISAWA PHARMACEUTICAL CO3 citations62
US4645765AFeb 24, 1987
Tetracyclo compounds and a pharmaceutical composition containing the same
FUJISAWA PHARMACEUTICAL CO4 citations62
US6730776B1May 4, 2004
WF14573 or its salt, production thereof and use thereof
FUJISAWA PHARMACEUTICAL CO2 citations61
US6399567B1Jun 4, 2002
Cyclic hexapeptides having antibiotic activity
FUJISAWA PHARMACEUTICAL CO4 citations61
US5436140AJul 25, 1995
Process for producing WS-9326A and WS-9326B
FUJISAWA PHARMACEUTICAL CO4 citations61
US6521600B1Feb 18, 2003
Compound, WF002, production thereof and use thereof
FUJISAWA PHARMACEUTICAL CO0 citations51
US5217952AJun 8, 1993
Peptides WS-9326a and WS-9326b, derivatives thereof and uses thereof
FUJISAWA PHARMACEUTICAL CO2 citations51
US4939241AJul 3, 1990
Amino acid derivatives of antitumor activity
FUJISAWA PHARMACEUTICAL CO1 citations51
US4861774AAug 29, 1989
Method of treating tumors using tetracyclo compounds
FUJISAWA PHARMACEUTICAL CO0 citations51
US4743555AMay 10, 1988
Biologically pure culture of Streptomyces sandaensis No. 6897
FUJISAWA PHARMACEUTICAL CO1 citations51